Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
1.855 USD | -2.37% |
|
+1.64% | -87.36% |
06-24 | Amylyx Pharmaceuticals, Inc.(NasdaqGS:AMLX) dropped from S&P Pharmaceuticals Select Industry Index | CI |
06-21 | Amylyx to buy bankrupt Eiger's experimental drug to treat low blood sugar | RE |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-87.36% | 129M | |
+2.08% | 95.18B | |
-0.13% | 37.55B | |
-10.52% | 33.75B | |
+77.76% | 28.2B | |
-14.93% | 15.63B | |
-2.80% | 13.63B | |
-12.76% | 11.5B | |
+181.73% | 10.81B | |
-53.92% | 9.23B |
- Stock Market
- Equities
- AMLX Stock
- News Amylyx Pharmaceuticals, Inc.
- Insider Sell: Amylyx Pharmaceuticals